Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Vascular Surgery

  Free Subscription

Articles published in Heart

Retrieve available abstracts of 115 articles:
HTML format

Single Articles

    January 2021
  1. CHARLA P, Karur GR, Yamamura K, Yoo SJ, et al
    Augmentation of pulmonary blood flow and cardiac output by non-invasive external ventilation late after Fontan palliation.
    Heart. 2021;107:142-149.
    PubMed     Abstract available

    December 2020
  2. DE FILIPPO O, D'Ascenzo F, Deferrari GM
    COVID-19 pandemic and infarctions: another call to reorganise our healthcare systems.
    Heart. 2020;106:1786-1787.

    October 2020
  3. MOHAMMAD MA, Koul S, Olivecrona GK, Gtberg M, et al
    Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic.
    Heart. 2020 Oct 6. pii: heartjnl-2020-317685. doi: 10.1136/heartjnl-2020-317685.
    PubMed     Abstract available

  4. NIJJER SS, Petraco R, Sen S
    Optimal management of acute coronary syndromes in the era of COVID-19.
    Heart. 2020;106:1609-1616.

    August 2020
  5. KWOK CS, Gale CP, Kinnaird T, Curzen N, et al
    Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.
    Heart. 2020 Aug 31. pii: heartjnl-2020-317650. doi: 10.1136/heartjnl-2020-317650
    PubMed     Abstract available

    July 2020
  6. WILLIAMS C, Brown DL
    Effect of random deferral of percutaneous coronary intervention in patients with diabetes and stable ischaemic heart disease.
    Heart. 2020 Jul 21. pii: heartjnl-2019-316432. doi: 10.1136/heartjnl-2019-316432
    PubMed     Abstract available

    June 2020
  7. HOOLE SP, Bambrough P
    Recent advances in percutaneous coronary intervention.
    Heart. 2020 Jun 10. pii: heartjnl-2019-315707. doi: 10.1136/heartjnl-2019-315707
    PubMed     Abstract available

    May 2020
  8. AL SAID S, Katus HA, Alabed S
    Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention.
    Heart. 2020 May 29. pii: heartjnl-2020-316726. doi: 10.1136/heartjnl-2020-316726

  9. KOO CY, Aung AT, Chen Z, Kristanto W, et al
    Sleep apnoea and cardiovascular outcomes after coronary artery bypass grafting.
    Heart. 2020 May 18. pii: heartjnl-2019-316118. doi: 10.1136/heartjnl-2019-316118
    PubMed     Abstract available

  10. HOOLE SP, Jenkins DP
    Chronic thromboembolic pulmonary hypertension: interventional approaches.
    Heart. 2020 May 13. pii: heartjnl-2019-316291. doi: 10.1136/heartjnl-2019-316291

  11. DALEY M, du Plessis K, Zannino D, Hornung T, et al
    Reintervention and survival in 1428 patients in the Australian and New Zealand Fontan Registry.
    Heart. 2020;106:751-757.
    PubMed     Abstract available

    April 2020
  12. THOMAS MR, Grove EL, Kirchhof P
    Complex antithrombotic combinations: how to find the perfect blend?
    Heart. 2020;106:557-558.

    March 2020
  13. WALD DS, Casey-Gillman O, Comer K, Mansell JS, et al
    Animation-supported consent for urgent angiography and angioplasty: a service improvement initiative.
    Heart. 2020 Mar 10. pii: heartjnl-2019-316227. doi: 10.1136/heartjnl-2019-316227
    PubMed     Abstract available

  14. QIN Y, Wei X, Han H, Wen Y, et al
    Association between age and readmission after percutaneous coronary intervention for acute myocardial infarction.
    Heart. 2020 Mar 6. pii: heartjnl-2019-316103. doi: 10.1136/heartjnl-2019-316103.
    PubMed     Abstract available

    Cloudy forecast for appropriate use criteria.
    Heart. 2020;106:407-408.

    Can we improve the appropriateness of PCI?
    Heart. 2020;106:405-406.

    February 2020
  17. IHDAYHID AR, Sapontis J
    The fractional flow reserve grey zone: a blueprint for the future of coronary revascularisation.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316435. doi: 10.1136/heartjnl-2019-316435

  18. HENNIGAN B, Berry C, Collison D, Corcoran D, et al
    Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316075. doi: 10.1136/heartjnl-2019-316075
    PubMed     Abstract available

  19. LUPERCIO F, Giancaterino S, Villablanca PA, Han F, et al
    P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2020 Feb 7. pii: heartjnl-2019-315963. doi: 10.1136/heartjnl-2019-315963.
    PubMed     Abstract available

  20. RIDDERBOS FS, Bonenkamp BE, Meyer SL, Eshuis G, et al
    Pulmonary artery size is associated with functional clinical status in the Fontan circulation.
    Heart. 2020;106:233-239.
    PubMed     Abstract available

  21. SANTIAGO DE ARAUJO PIO C, Chaves G, Davies P, Taylor R, et al
    Cochrane corner: increasing patient utilisation of cardiac rehabilitation.
    Heart. 2020;106:248-250.

    December 2019
  22. YANG JX, Stevenson MJ, Valsdottir L, Ho K, et al
    Association between procedure appropriateness and patient-reported outcomes after percutaneous coronary intervention.
    Heart. 2019 Dec 19. pii: heartjnl-2019-315835. doi: 10.1136/heartjnl-2019-315835
    PubMed     Abstract available

    November 2019
  23. DONDO TB, Hall M, Munyombwe T, Wilkinson C, et al
    A nationwide causal mediation analysis of survival following ST-elevation myocardial infarction.
    Heart. 2019 Nov 15. pii: heartjnl-2019-315760. doi: 10.1136/heartjnl-2019-315760
    PubMed     Abstract available

    October 2019
  24. YU CW
    Does thrombectomy inhibit effect of ischaemic postconditioning in STEMI? True or not?
    Heart. 2019 Oct 14. pii: heartjnl-2019-315389. doi: 10.1136/heartjnl-2019-315389

    July 2019
  25. NEPPER-CHRISTENSEN L, Hofsten DE, Helqvist S, Lassen JF, et al
    Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.
    Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952
    PubMed     Abstract available

    May 2019
  26. MATIC DM, Asanin MR, Vukcevic VD, Mehmedbegovic ZH, et al
    Impact on long-term mortality of access and non-access site bleeding after primary percutaneous coronary intervention.
    Heart. 2019 May 25. pii: heartjnl-2019-314728. doi: 10.1136/heartjnl-2019-314728
    PubMed     Abstract available

    March 2019
    Hypoplastic left heart syndrome: the importance of phenotypic diagnosis.
    Heart. 2019;105:499.

    January 2019
  28. ZUSMAN O, Bebb O, Hall M, Dondo TB, et al
    International comparison of acute myocardial infarction care and outcomes using quality indicators.
    Heart. 2019 Jan 30. pii: heartjnl-2018-314197. doi: 10.1136/heartjnl-2018-314197
    PubMed     Abstract available

  29. DAVENPORT ED, Syburra T, Gray G, Rienks R, et al
    Management of established coronary artery disease in aircrew with previous myocardial infarction or revascularisation.
    Heart. 2019;105.
    PubMed     Abstract available

    December 2018
  30. FEINBERG J, Nielsen EE, Gluud C, Jakobsen JC, et al
    Cochrane Corner: drug-eluting stents versus bare-metal stents for acute coronary syndrome.
    Heart. 2018;104:1895-1897.

    Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update.
    Heart. 2018;104:1976-1983.

    November 2018
  32. HUANG HD, Lombardi WL, Steinberg ZL
    Young man presenting with out-of-hospital cardiac arrest.
    Heart. 2018;104:1771-1802.
    PubMed     Abstract available

  33. HEUTS S, Adriaans BP, Gerretsen S, Natour E, et al
    Aortic elongation part II: the risk of acute type A aortic dissection.
    Heart. 2018;104:1778-1782.
    PubMed     Abstract available

    October 2018
  34. TESTORI C, Beitzke D, Mangold A, Sterz F, et al
    Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: a randomised trial.
    Heart. 2018 Oct 25. pii: heartjnl-2018-313705. doi: 10.1136/heartjnl-2018-313705
    PubMed     Abstract available

  35. OTTO CM
    Heartbeat: improving outcomes after myocardial infarction.
    Heart. 2018;104:1553-1554.

    September 2018
  36. AL-LAMEE RK, Nowbar AN, Francis DP
    Percutaneous coronary intervention for stable coronary artery disease.
    Heart. 2018 Sep 21. pii: heartjnl-2017-312755. doi: 10.1136/heartjnl-2017-312755
    PubMed     Abstract available

  37. LEE SE, Lee HY, Cho HJ, Choe WS, et al
    Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313242. doi: 10.1136/heartjnl-2018-313242
    PubMed     Abstract available

  38. OTTO CM
    Heartbeat: The ongoing controversy of intervention for chronic total coronary occlusions.
    Heart. 2018;104:1385-1387.

  39. SCHWARTZ I, McCracken CE, Petit CJ, Sachdeva R, et al
    Late outcomes after the Fontan procedure in patients with single ventricle: a meta-analysis.
    Heart. 2018;104:1508-1514.
    PubMed     Abstract available

  40. GALAPPATTHY P, Bataduwaarachchi VR, Ranasinghe P, Galappatthy GKS, et al
    Management, characteristics and outcomes of patients with acute coronary syndrome in Sri Lanka.
    Heart. 2018;104:1424-1431.
    PubMed     Abstract available

    June 2018
  41. FAHEY JK, Ihdayhid AR, White AJ
    A 42-year-old woman with acute myocardial infarction.
    Heart. 2018 Jun 28. pii: heartjnl-2017-312779. doi: 10.1136/heartjnl-2017-312779

  42. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.

    May 2018
  43. KANDAN SR, Johnson TW
    Management of percutaneous coronary intervention complications.
    Heart. 2018 May 14. pii: heartjnl-2017-311155. doi: 10.1136/heartjnl-2017-311155

  44. VANEZIS AP, Arnold JR, Rodrigo G, Lai FY, et al
    Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial.
    Heart. 2018 May 10. pii: heartjnl-2018-313091. doi: 10.1136/heartjnl-2018-313091
    PubMed     Abstract available

    April 2018
    Clinical outcomes of potent antiplatelets compared with clopidogrel in ST elevation myocardial infarction.
    Heart. 2018 Apr 17. pii: heartjnl-2018-312967. doi: 10.1136/heartjnl-2018-312967

    New interventions to treat chronic thromboembolic pulmonary hypertension.
    Heart. 2018 Apr 10. pii: heartjnl-2017-312110. doi: 10.1136/heartjnl-2017-312110
    PubMed     Abstract available

  47. AVITABILE CM, Goldberg DJ, Leonard MB, Wei ZA, et al
    Leg lean mass correlates with exercise systemic output in young Fontan patients.
    Heart. 2018;104:680-684.
    PubMed     Abstract available

    March 2018
  48. JOHNSTONE SR, Isakson BE
    'Gaps' in targeted ischaemic injury therapies in ST-elevation myocardial infarction.
    Heart. 2018 Mar 30. pii: heartjnl-2018-313084. doi: 10.1136/heartjnl-2018-313084

  49. ENGSTROM T, Nepper-Christensen L, Helqvist S, Klovgaard L, et al
    Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.
    Heart. 2018 Mar 30. pii: heartjnl-2017-312774. doi: 10.1136/heartjnl-2017-312774
    PubMed     Abstract available

  50. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.

  51. CAULDWELL M, Steer PJ, Bonner S, Asghar O, et al
    Retrospective UK multicentre study of the pregnancy outcomes of women with a Fontan repair.
    Heart. 2018;104:401-406.
    PubMed     Abstract available

    Rotational atherectomy: re-emergence of an old technique.
    Heart. 2018;104:440-448.

  53. STOJKOVIC S, Milasinovic D
    Chronic total occlusion percutaneous coronary intervention in clinical practice: novel grounds to be EXPLOREd.
    Heart. 2018 Mar 1. pii: heartjnl-2018-312940. doi: 10.1136/heartjnl-2018-312940.

    February 2018
  54. GARCIA-ARRIBAS D, Vilacosta I, Ortega Candil A, Rodriguez Rey C, et al
    Usefulness of positron emission tomography/computed tomography in patients with valve-tube graft infection.
    Heart. 2018 Feb 22. pii: heartjnl-2017-312918. doi: 10.1136/heartjnl-2017-312918
    PubMed     Abstract available

  55. ELIAS J, van Dongen IM, Ramunddal T, Laanmets P, et al
    Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.
    Heart. 2018 Feb 20. pii: heartjnl-2017-312698. doi: 10.1136/heartjnl-2017-312698
    PubMed     Abstract available

  56. BRAVO CA, Hirji SA, Bhatt DL, Gluud C, et al
    Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease.
    Heart. 2018 Feb 8. pii: heartjnl-2017-312857. doi: 10.1136/heartjnl-2017-312857.

  57. FOO CY, Bonsu KO, Nallamothu BK, Reid CM, et al
    Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.
    Heart. 2018 Feb 5. pii: heartjnl-2017-312517. doi: 10.1136/heartjnl-2017-312517.
    PubMed     Abstract available

  58. GAASCH WH, Meyer TE
    Secondary mitral regurgitation (part 2): deliberations on mitral surgery and transcatheter repair.
    Heart. 2018 Feb 2. pii: heartjnl-2017-312002. doi: 10.1136/heartjnl-2017-312002.
    PubMed     Abstract available

  59. OLIER I, Sirker A, Hildick-Smith DJR, Kinnaird T, et al
    Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention.
    Heart. 2018 Feb 2. pii: heartjnl-2017-312366. doi: 10.1136/heartjnl-2017-312366.
    PubMed     Abstract available

  60. HAYS BS, Baker M, Laib A, Tan W, et al
    Histopathological abnormalities in the central arteries and veins of Fontan subjects.
    Heart. 2018;104:324-331.
    PubMed     Abstract available

  61. AVERIN K, Byrnes JW, Benscoter DT, Whiteside W, et al
    Life-threatening airway bleeding after palliation of single ventricle congenital heart disease.
    Heart. 2018;104:254-260.
    PubMed     Abstract available

  62. LATUS H, Nassar MS, Wong J, Hachmann P, et al
    Ventricular function and vascular dimensions after Norwood and hybrid palliation of hypoplastic left heart syndrome.
    Heart. 2018;104:244-252.
    PubMed     Abstract available

    January 2018
  63. AKOUM N
    Persistently high incidence of postcoronary bypass atrial fibrillation: possible mechanisms.
    Heart. 2018 Jan 19. pii: heartjnl-2017-312627. doi: 10.1136/heartjnl-2017-312627

  64. FILARDO G, Damiano RJ Jr, Ailawadi G, Thourani VH, et al
    Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312150. doi: 10.1136/heartjnl-2017-312150
    PubMed     Abstract available

  65. SMILOWITZ NR, Gupta N, Guo Y, Beckman JA, et al
    Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery.
    Heart. 2018 Jan 5. pii: heartjnl-2017-312391. doi: 10.1136/heartjnl-2017-312391.
    PubMed     Abstract available

  66. ARRI SS, Patterson T, Williams RP, Moschonas K, et al
    Myocardial revascularisation in high-risk subjects.
    Heart. 2018;104:166-179.

  67. MAZNYCZKA AM, McCartney P, Berry C
    Reference invasive tests of microvascular injury in myocardial infarction.
    Heart. 2018;104:90-92.

  68. DE WAARD GA, Fahrni G, de Wit D, Kitabata H, et al
    Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.
    Heart. 2018;104:127-134.
    PubMed     Abstract available

    December 2017
  69. QUANDT D, Ramchandani B, Penford G, Stickley J, et al
    Right ventricular outflow tract stent versus BT shunt palliation in Tetralogy of Fallot.
    Heart. 2017;103:1985-1991.
    PubMed     Abstract available

  70. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    PubMed     Abstract available

  71. DE CARLO M, Liga R
    Elderly patients with non-ST-elevation acute coronary syndromes: a call for action.
    Heart. 2017;103:1932-1933.

    November 2017
  72. TOYOTA T, Morimoto T, Shiomi H, Yamaji K, et al
    Single-session versus staged procedures for elective multivessel percutaneous coronary intervention.
    Heart. 2017 Nov 16. pii: heartjnl-2017-312117. doi: 10.1136/heartjnl-2017-312117
    PubMed     Abstract available

  73. GRAY AM, Murphy J, Altman DG, Benedetto U, et al
    One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
    Heart. 2017;103:1719-1726.
    PubMed     Abstract available

  74. TANG E, Wei ZA, Whitehead KK, Khiabani RH, et al
    Effect of Fontan geometry on exercise haemodynamics and its potential implications.
    Heart. 2017;103:1806-1812.
    PubMed     Abstract available

  75. EGBE AC, Khan AR, Ammash NM, Barbara DW, et al
    Predictors of procedural complications in adult Fontan patients undergoing non-cardiac procedures.
    Heart. 2017;103:1813-1820.
    PubMed     Abstract available

  76. SILVAIN J, Nguyen LS, Spagnoli V, Kerneis M, et al
    Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311975. doi: 10.1136/heartjnl-2017-311975.
    PubMed     Abstract available

  77. SINDET-PEDERSEN C, Staerk L, Lamberts M, Gerds TA, et al
    Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311976. doi: 10.1136/heartjnl-2017-311976.
    PubMed     Abstract available

    October 2017
  78. DE MARIA GL, Patel N, Banning AP
    Obstructive left main stem coronary disease: is it time to recommend coronary stenting?
    Heart. 2017 Oct 23. pii: heartjnl-2016-310880. doi: 10.1136/heartjnl-2016-310880

  79. WANG N, Fulcher J, Abeysuriya N, Adams M, et al
    Predictors of successful chronic total occlusion percutaneous coronary interventions: a systematic review and meta-analysis.
    Heart. 2017 Oct 6. pii: heartjnl-2017-311986. doi: 10.1136/heartjnl-2017-311986.
    PubMed     Abstract available

  80. OHUCHI H, Negishi J, Hayama Y, Miyazaki A, et al
    Renal resistive index reflects Fontan pathophysiology and predicts mortality.
    Heart. 2017;103:1631-1637.
    PubMed     Abstract available

    September 2017
  81. PICCOLO R, Franzone A, Windecker S
    From bare metal to barely anything: an update on coronary stenting.
    Heart. 2017 Sep 19. pii: heartjnl-2016-310877. doi: 10.1136/heartjnl-2016-310877

  82. BUTTAR SN, Yan TD, Taggart DP, Tian DH, et al
    Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis.
    Heart. 2017;103:1419-1426.
    PubMed     Abstract available

  83. NAIROOZ R, Saad M, Elgendy IY, Mahmoud AN, et al
    Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials.
    Heart. 2017;103:1427-1434.
    PubMed     Abstract available

    August 2017
  84. ALFREDSSON J, Neely B, Neely ML, Bhatt DL, et al
    Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
    Heart. 2017;103:1168-1176.
    PubMed     Abstract available

    July 2017
    Arterial grafting for coronary revascularisation and the illusive search for truth.
    Heart. 2017 Jul 12. pii: heartjnl-2017-311289. doi: 10.1136/heartjnl-2017-311289

  86. UDINK TEN CATE FEA, Trieschmann U, Germund I, Hannes T, et al
    Stenting the Fontan pathway in paediatric patients with obstructed extracardiac conduits.
    Heart. 2017;103:1111-1116.
    PubMed     Abstract available

  87. NAIROOZ R, Saad M, Sardar P, Aronow WS, et al
    Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
    Heart. 2017;103:1096-1103.
    PubMed     Abstract available

  88. BRUGALETTA S, Sabate M
    A longer look at trial evidence of bioresorbable vascular scaffolds.
    Heart. 2017;103:1061-1062.

    June 2017
  89. COCKBURN J, Hildick-Smith DJ, Trivedi U, de Belder AJ, et al
    Re: A case for palliative percutaneous coronary intervention.
    Heart. 2017;103:967.

  90. BLAKE SR
    A case for palliative percutaneous coronary intervention.
    Heart. 2017;103:967.

    April 2017
  91. WILSON SJ, Newby DE, Dawson D, Irving J, et al
    Duration of dual antiplatelet therapy in acute coronary syndrome.
    Heart. 2017;103:573-580.
    PubMed     Abstract available

  92. NADIR MA
    Inverse prognostic value of post-percutaneous coronary intervention fractional flow reserve in patients with non-ST segment elevation myocardial infarction.
    Heart. 2017;103:564.

    March 2017
  93. OPOTOWSKY AR, Baraona FR, Mc Causland FR, Loukas B, et al
    Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
    Heart. 2017;103:434-442.
    PubMed     Abstract available

  94. CAVALCANTE R, Sotomi Y, Zeng Y, Lee CW, et al
    Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Heart. 2017;103:428-433.
    PubMed     Abstract available

  95. MOSS AJ, Dweck MR, Flapan AD
    A 33-year-old man with atypical chest pain.
    Heart. 2017;103:474.
    PubMed     Abstract available

  96. HARBRON RW, Chapple CL, O'Sullivan JJ, Best KE, et al
    Survival adjusted cancer risks attributable to radiation exposure from cardiac catheterisations in children.
    Heart. 2017;103:341-346.
    PubMed     Abstract available

    February 2017
  97. KIM YY, Rathod RH, Gauvreau K, Keenan EM, et al
    Factors associated with severe aortic dilation in patients with Fontan palliation.
    Heart. 2017;103:280-286.
    PubMed     Abstract available

  98. LEDWOCH J, Fuernau G, Desch S, Eitel I, et al
    Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock.
    Heart. 2017 Feb 7. pii: heartjnl-2016-310403. doi: 10.1136/heartjnl-2016-310403.
    PubMed     Abstract available

    January 2017
  99. ALSAIED T, Bokma JP, Engel ME, Kuijpers JM, et al
    Factors associated with long-term mortality after Fontan procedures: a systematic review.
    Heart. 2017;103:104-110.
    PubMed     Abstract available

  100. DANZI GB, Piccolo R, Chevalier B, Urban P, et al
    Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.
    Heart. 2017;103:111-116.
    PubMed     Abstract available

  101. VARCOE RW, Clayton TC, Gray HH, de Belder MA, et al
    Impact of call-to-balloon time on 30-day mortality in contemporary practice.
    Heart. 2017;103:117-124.
    PubMed     Abstract available

  102. CASSESE S, Xhepa E, Kastrati A
    Biodegradable-polymer drug-eluting stents: back to the future?
    Heart. 2017;103:91-92.

    December 2016
  103. KIM NH, D'Armini AM, Grimminger F, Grunig E, et al
    Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
    Heart. 2016 Dec 23. pii: heartjnl-2016-309621. doi: 10.1136/heartjnl-2016-309621
    PubMed     Abstract available

  104. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Reiter RJ
    Melatonin for cardioprotection in ST elevation myocardial infarction: are we ready for the challenge?
    Heart. 2016 Dec 7. pii: heartjnl-2016-310689. doi: 10.1136/heartjnl-2016-310689.

    November 2016
  105. EISEN A, Bhatt DL
    Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting.
    Heart. 2016 Nov 25. pii: heartjnl-2015-309022. doi: 10.1136/heartjnl-2015-309022

    September 2016
  106. JONES DA, Khambata RS, Andiapen M, Rathod KS, et al
    Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention.
    Heart. 2016 Sep 28. pii: heartjnl-2016-309748. doi: 10.1136/heartjnl-2016-309748
    PubMed     Abstract available

    August 2016
  107. SHAH R, Mooney MA
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335.

  108. NAVARESE E, Kowalewski M
    Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
    Heart. 2016;102:1335-6.

  109. MCWILLIAMS E, Zehr K, Alshehri A
    An unusual shadow above the aortic valve.
    Heart. 2016 Aug 11. pii: heartjnl-2016-309932. doi: 10.1136/heartjnl-2016-309932
    PubMed     Abstract available

  110. MANGION K, Carrick D, Hennigan BW, Payne AR, et al
    Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.
    Heart. 2016 Aug 8. pii: heartjnl-2015-308660. doi: 10.1136/heartjnl-2015-308660.
    PubMed     Abstract available

    July 2016
  111. DI TANO G, Caretta G, De Maria R, Parolini M, et al
    Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Heart. 2016 Jul 27. pii: heartjnl-2016-309673. doi: 10.1136/heartjnl-2016-309673
    PubMed     Abstract available

  112. PETRONI T, Zaman A, Georges JL, Hammoudi N, et al
    Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians.
    Heart. 2016 Jul 13. pii: heartjnl-2015-308905. doi: 10.1136/heartjnl-2015-308905
    PubMed     Abstract available

    June 2016
  113. SIZAROV A, Raimondi F, Bonnet D, Boudjemline Y, et al
    Vascular anatomy in children with pulmonary hypertension regarding the transcatheter Potts shunt.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309352. doi: 10.1136/heartjnl-2016-309352
    PubMed     Abstract available

    May 2016
  114. FUKUI S, Ogo T, Takaki H, Ueda J, et al
    Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Heart. 2016 May 24. pii: heartjnl-2015-309230. doi: 10.1136/heartjnl-2015-309230
    PubMed     Abstract available

    March 2016
  115. SHI WY, Yong MS, McGiffin DC, Jain P, et al
    Heart transplantation in Fontan patients across Australia and New Zealand.
    Heart. 2016 Mar 21. pii: heartjnl-2015-308848. doi: 10.1136/heartjnl-2015-308848
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.